Adria Warren is a partner and health care M&A and regulatory lawyer with deep experience advising hospitals, providers, and health care enterprises on complex transactions, corporate, and regulatory compliance matters. Her experience includes mergers, acquisitions, joint ventures, and other affiliations and strategic transactions; forming provider groups, networks, and alliances; and advising on fraud and abuse, corporate practice of medicine, privacy and security (HIPAA) and other specialized health regulatory compliance, employment, and reporting and disclosure requirements. Adria has specialized experience in oncology transactions and is a frequent speaker and contributor on issues unique to the field.
“She knows the healthcare space in the northeast and is an integral part of the team.” — Chambers USA
A partner with over two decades of experience Adria brings a wealth of business and transactional experience to assist clients in the health care industry, including hospitals and health systems, providers, private equity, medical device companies, life sciences companies, and health care information technology companies. In addition, Adria counsels entrepreneurs and established companies on a wide range of day-to-day legal and business issues from starting-up through going public, including corporate governance issues, securities laws compliance, tax, and employment matters. Adria is a member of the firm’s Health Care & Life Science Sector.
Experiência de representação
- Representou a Sports Medicine North Orthopedic Surgery, Inc., e o seu centro de cirurgia ambulatória afiliado na sua aquisição pela organização de serviços de gestão de cuidados ortopédicos e da coluna vertebral Spire Orthopedic Partners, sediada no Connecticut, uma empresa do portfolio da Kohlberg & Co.
- Advised Saint Luke’s Health System on its US $40MM acquisition, through a long-term lease, of a publicly-held critical access hospital.
- Served as outside general counsel for over three years for New England Baptist Hospital, a specialty orthopaedic hospital in Boston.
- Advised New England Baptist Hospital on its consolidation with Beth Israel Deaconess Medical Center, Lahey Health System, Mount Auburn Hospital, and Anna Jaques Hospital to form Beth Israel Lahey Health.
- Advised regional developer of ambulatory surgery centers in connection with the transaction structuring, development and implementation of multiple ambulatory surgical centers, including securities offerings and regulatory advice.
- Advised Emerson Hospital in connection with negotiating, documenting and implementing two imaging center joint ventures.
- Represented multiple oncology practices in their affiliation with hospitals and private equity-backed platform companies.
- Advised multiple physician groups in sales to hospitals, health systems, health management organizations and private equity.
- Multiple physician group affiliations and corporate reorganizations.
- Advised multiple providers and hospital system clients in connection with new physician alignment models and strategies, including leasing, professional services and employment arrangements.
- Supported the corporate reorganization of a physician group consisting of over 500 physicians, including advising on corporate governance and compensation matters.
- Advised Cobius Healthcare Solutions, a leading provider of reimbursement and compliance risk management tools for hospitals and healthcare systems, on its sale to MRO Corporation.
- Advised life sciences, health information technology (IT) and infomatics companies on regulatory compliance needs.
- Relationship partner supporting all the health transaction and regulatory needs for a large regional health system that includes 18 hospitals and campuses.
International Experience
- Lived in China from 1990-1993 and in 1996, and has worked extensively with China and Southeast Asia in numerous capacities.
Liderança de pensamento
Adria speaks and writes frequently on health care legal matters, including for Health Care Law Today, the Cancer Center Business Summit (the preeminent national conference focusing on the business of oncology), Strafford, the Boston Bar Association, the Association of Corporate Counsel, the National Law Review, and MCLE New England. Some illustrative recent examples are below.
- Coautor, "Massachusetts: Expansão da Autoridade de Supervisão - Novo Formulário de Notificação de Alteração Material para Transacções de Cuidados de Saúde," Health Care Law Today (27 de março de 2025)
- Speaker, “Navigating Reimbursement Realities: Challenges & Opportunities in Value-Based Cancer Care,” CancerX Webinar (February 12, 2025)
- Coautor, "Private Equity Investments in Oncology: Top Five Things to Know," Journal of Health Care Compliance (janeiro de 2025)
- Co-author, “Reimagining Home-Based Cancer Care: Key Legal and Regulatory Considerations,” Health Care Law Today (October 7, 2024)
- Coautor, "Inteligência Artificial nos Cuidados de Saúde: Key Considerations for Oncology," Health Care Law Today (25 de setembro de 2024)
- Co-author, “The 340B Drug Pricing Program: Top Five Things to Know,” Health Care Law Today (September 17, 2024)
- Coautor, "Massachusetts Health Care Act Dies at the End of Legislative Session But Previews Sweeping Changes for the Health Care Industry," Health Care Law Today (5 de agosto de 2024)
- Moderator, “Risk & Rewards of Oncology Joint Ventures & Strategic Partnerships,” Clinical Pathways Congress + Cancer Care Business Exchange (September 6, 2024)
- Speaker, “Hospital Acquisitions of Physician Practices,” Strafford (Dec. 2023)
- Panelist, “Consolidation in the Oncology Industry,” 2023 HMP Cancer Care Business Exchange (Oct. 2023)
- Regular speaker and author on “Hospital Law Basics” for MCLE New England Massachusetts Health and Hospital Law Manual
- Speaker, “Emergent Payment Issues in Oncology”, Association of Community Cancer Centers (ACCC) Annual Meeting & Cancer Business Summit (AMCCBS) Conference (March 2023)
- Co-author, “The Future of the 340B Program: 2023 Key Decisions,” Health Care Law Today (March 2023)
- Speaker, “Forming Physician Supergroups: Structural and Regulatory Challenges”, Strafford Webinar (June 2023)
- Speaker, “Industry Consolidation: The Nuts & Bolts,” The ACCC 48th Annual Meeting & Cancer Center Business Summit (March 2022)
- Co-author, “Nevada is Latest State to Enhance Oversight of Health Care Transactions,” Health Care Law Today (September 2021)
- Co-author, “New Advisory Opinion on ASCs: New Flexibilities (Or Not?), Health Care Law Today (July 2021)
- Co-author, “Stark Law Changes Coming to Physician Compensation Models in 2022,” Health Care Law Today (May 2021)
- Speaker, “The 2021 ‘Level Set in the Sprint to Value-Based Care,” The ACCC 47th Annual Meeting & Cancer Center Business Summit (March 2021)
- Speaker, “Current Deal Trends in Oncology,” The ACCC 47th Annual Meeting & Cancer Center Business Summit (March 2021)
Liderança
- Training Chair, Foley & Lardner Health Care Practice Group
- Advisory Board Member, HMP Cancer Care Business Exchange
- Contributor, CancerX, a public-private partnership to boost innovation in the fight against cancer
- Co-Chair, Foley & Lardner National Women’s Network (2015-2023)
- Adjunct Lecturer on Health Transactions, Boston University School of Law
Reconhecimento
- Recognized in Chambers USA for her work in Health Care Law (2021-2025)
- Named a Thomson Reuters Stand-out Lawyer (2024-2025)
- Selected by her peers for inclusion in The Best Lawyers in America® list in the field of Health Care Law since 2019
- Named a Top Massachusetts Woman Attorney in “Super Lawyers and Rising Stars” in 2019
Professional Memberships and Affiliations
- Boston University Law School of Law adjunct faculty, teaching “Health Transactions”
- HMP Cancer Care Business Exchange – Advisory Board
- Board of Directors of the Marino Foundation, a grant-making organization working to promote the advancement of integrative medicine”
- Previously served on the Steering Committee of the Boston Bar Association’s Health Law Committee, and co-chaired its Education Subcommittee (2015 to 2018)
- Previously co-chaired the China Committee for the American Bar Association’s Section of International Law, and editor of its “Year in Review (China)”
Beyond the Hype Part 1: Real-World Impact of AI-Powered Clinical Documentation
Foley partner Adria Warren is speaking at the 2025 Clinical Pathways Congress + Cancer Care Business Exchange on September 5.
Physician Noncompetes: Texas Restrictions Apply to Dentists, Physicians’ Assistants, and Nurses
On June 20, 2025, Texas Governor Greg Abbott signed into law Senate Bill 1318 (SB 1318), which will further restrict noncompete agreements for health care professionals in Texas, starting September 1, 2025.
Foley obtém as melhores classificações na Chambers USA 2025
Foley & Lardner LLP orgulha-se de, mais uma vez, ser reconhecida pela Chambers & Partners como uma das principais sociedades de advogados do país na edição de 2025 da Chambers USA: America's Leading Lawyers for Business.
Massachusetts: Expansão da Autoridade de Supervisão - Novo Formulário de Notificação de Alteração Material para Transacções de Cuidados de Saúde
A Massachusetts Health Policy Commission (Comissão de Política de Saúde de Massachusetts), uma agência estatal independente que trabalha para melhorar a acessibilidade dos preços dos cuidados de saúde para os residentes da Commonwealth, publicou Advance Guidance para "Prestadores" e "Organizações de Prestadores" que consideram transacções sujeitas ao processo atualizado de Notice of Material Change (Aviso de Alteração Material) da HPC.
Navigating Reimbursement Realities: Challenges & Opportunities in Value-Based Cancer Care
On February 12, Foley partners Kinal Patel, co-chair of the firm’s Payor/Provider Convergence Area of Focus, and Adria Warren are hosting CancerX’s upcoming webinar “Navigating Reimbursement Realities: Challenges & Opportunities in Value-Based Cancer Care” with Jasper Health’s CEO Erich Mounce.
Private Equity Investments in Oncology: Top Five Things to Know
Although private equity (PE) sponsors have been active investors in the health care services industry for the last decade, PE-backed health care providers today constitute only 4% of the United States health market by revenue.